Position in ABBV
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$2,515,393
+$300,040 QoQ
Shares Held
9,996
-1.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#1,781
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026XML Financial, LLC holds $41,755,485 across 10 Drug Manufacturers - General names. ABBV ranks #5 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
60,680 | $15,410,899 | |
| 2 | MRK |
Merck & Co., Inc.
|
59,108 | $7,595,378 | |
| 3 | AMGN |
Amgen Inc
|
18,659 | $6,756,797 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
46,441 | $2,675,930 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
9,996 | $2,515,393 | |
| 6 | PFE |
Pfizer Inc
|
99,422 | $2,394,081 | |
| 7 | LLY |
ELI LILLY & Co
|
1,921 | $2,304,105 | |
| 8 | NVS |
Novartis AG
|
5,376 | $842,526 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,515,393 | 9,996 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $2,215,353 | 10,186 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $2,325,799 | 10,179 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,545,087 | 10,992 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $2,080,614 | 11,209 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $2,445,098 | 11,670 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $2,522,984 | 14,198 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $2,803,031 | 14,194 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $2,462,855 | 14,359 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $2,672,499 | 14,676 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,616,978 | 16,887 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,486,767 | 16,683 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $2,283,134 | 16,946 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $2,744,032 | 17,218 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,184,738 | 50,645 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $6,774,383 | 50,476 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,260,200 | 8,228 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $8,160,131 | 50,337 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $6,831,607 | 50,455 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $5,441,178 | 50,442 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $782,848 | 6,950 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $757,215 | 6,997 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $846,592 | 7,901 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $594,122 | 6,783 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $480,198 | 4,891 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $306,664 | 4,025 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||